Type 2 Diabetes
The relationship between bullous pemphigoid and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.
Investigators analyzed real world data to examine the risk for below-knee amputations in patients with type 2 diabetes taking canagliflozin vs other medications.
Investigators examined the effectiveness of oral agents vs insulin as an initial treatment option for people newly diagnosed with type 2 diabetes.
Investigators examined the efficacy of liraglutide for the prevention of dementia in elderly patients with type 2 diabetes.
Investigators examined the prevalence of chronic kidney disease in adults with type 1 diabetes compared with type 2 diabetes.
MEDI0382 reduced body weight and normalized fasting and postprandial blood glucose levels in patients with type 2 diabetes.
Investigators examined the incidence and outcomes of pneumonia in patients with acute ischemic stroke and type 2 diabetes.
Increased risk of subsequent diabetes independent of traditional diabetes risk factors
Per-person diabetes-attributable costs ranged from 374 in New Mexico to 1,610 in Washington, D.C.
For patients with type 2 diabetes, sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 agonists significantly reduce mortality rates compared with dipeptidyl peptidase 4 inhibitors.
The CDC conducted a study to estimate the prevalence of diagnosed diabetes among adults in 2016 by primary type.
A 68-year-old patient with type 2 diabetes presents to a urologist to evaluate funguria, and a CT scan showed right hydroureteronephrosis.
Patients with type 2 diabetes have a greater risk for developing inflammatory bowel disease when using dipeptidyl peptidase-4 inhibitors.
ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.
A high fiber diet promotes gut bacteria that helps blood glucose control in patients with type 2 diabetes.
The American College of Physicians has developed recommendation statements to guide clinicians in selecting targets for pharmacologic treatment of type 2 diabetes.
The incidence of ovarian cancer was not related to metformin or statin usage among women with type 2 diabetes.
Women with gestational diabetes have a greater risk of developing T2D and cardiovascular events than women who were not previously diagnosed with the disease.
With the help of a doctor and a weight loss plan, new research suggests type 2 diabetes can be reversed in less than a year.
The FDA has approved semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Primary care referral to Weight Watchers meetings is associated with weight loss, HbA1c reduction.
Statins are associated with an increased risk for developing type 2 diabetes, especially for high-risk individuals.
CBGT did not prevent overweight and obese patients with type 2 diabetes from regaining weight lost during weight loss programs.
Type 2 diabetes risk is increased in young adults through antidepressant use, specifically the duration of use and the cumulative dose.
Type 2 diabetes is greater with second-generation antipsychotics than with non-second-generation antipsychotic psychotropic medications for patients aged 6 to 25 years.
After the inclusion of recent negative studies, a statistically significant association between AD use and diabetes was observed.
Sleep duration for 1 hour longer was associated with lower BMI, fat mass, insulin resistance, and fasting glucose but had no effect on HbA1c or cardiovascular risk.
Lifestyle interventions maintain glycemic control in patients with type 2 diabetes.
Women who experienced early menopause were 2.4 times more likely to develop diabetes.
Adulthood weight gain is associated with an increased risk of major chronic diseases and mortality.